China: Patent

중국의 국가지식재산권국, 공안부, 국가시장감독관리총국이 지식재산권 대리업계의 정비 및 규범화를 위한 전국적 활동을 추진합니다. 불법 대리인 단ፚ

최근,국가지식재산권국 및 공업정보화는 <<2026년 중소기업을 위한 지식재산권 공공서비스 특별활동>>을 공동 추진하기로 결정했다고 발표하였다.

China's Supreme People's Court has issued its first public decision clarifying the country's inventorship standards, revealing significant differences from U.S. patent law...

The Supreme People's Court of China has issued a landmark judgment addressing the boundaries of patent infringement in the pesticide industry, specifically examining whether manufacturing...

中国最高人民法院在一起外观设计专利无效行政纠纷案中，明确了现有设计特征组合判断的关键标准，包括随意划分的设计元素不能作为组合特征

最高人民法院对一起农药发明专利侵权纠纷案作出终审判决。

To strengthen intellectual property protection, improve the quality and efficiency of administrative enforcement, deter infringing activities, and foster a better business and innovation environment...

China's National Medical Products Administration has introduced new Implementation Measures for the Protection of Drug Trial Data, establishing a dual-track system of patent and data protection for pharmaceuticals. The measures grant data exclusivity periods ranging from 3 to 6 years for innovative drugs, improved new drugs, and generic drugs, with significant changes from earlier drafts including removal of time-gap reductions and extended protection for improved formulations.

China's National Medical Products Administration has finalized groundbreaking regulatory data protection measures that grant up to 6 years of market exclusivity for innovative drugs, fundamentally...